ArticlePharmaceuticals (Basel, Switzerland)2025
Indazole Derivatives Against Murine Cutaneous Leishmaniasis.
Niurka Mollineda-Diogo, Yunierkis Pérez-Castillo, Sergio Sifontes-Rodríguez, Osmani Marrero-Chang, Alfredo Meneses-Marcel, Alma Reyna Escalona-Montaño, María Magdalena Aguirre-García, Teresa Espinosa-Buitrago, Yeny Morales-Moreno, Vicente Arán-Redó
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Niurka Mollineda-DiogoCentro de Bioactivos Químicos, Universidad Central "Marta Abreu" de Las Villas, Santa Clara 54800, Villa Clara, Cuba.ORCID 0000-0001-5137-0253 Yunierkis Pérez-CastilloGrupo de Bio-Quimioinformática and Facultad de Ingeniería y Ciencias Aplicadas, Universidad de Las Américas, Quito 170125, Ecuador.ORCID 0000-0002-3710-0035 Sergio Sifontes-RodríguezInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México-Consejo Nacional de Humanidades, Ciencias y Tecnologías (CONAHCYT), Ciudad de México 14080, Mexico.ORCID 0000-0003-1226-8648 Osmani Marrero-ChangCentro de Bioactivos Químicos, Universidad Central "Marta Abreu" de Las Villas, Santa Clara 54800, Villa Clara, Cuba.
Alfredo Meneses-MarcelCentro de Bioactivos Químicos, Universidad Central "Marta Abreu" de Las Villas, Santa Clara 54800, Villa Clara, Cuba.
Alma Reyna Escalona-MontañoUnidad de Investigación UNAM-INC, Facultad de Medicina, Universidad Nacional Autónoma de México-Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México 14080, Mexico.ORCID 0000-0002-0060-2939 María Magdalena Aguirre-GarcíaUnidad de Investigación UNAM-INC, Facultad de Medicina, Universidad Nacional Autónoma de México-Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México 14080, Mexico.ORCID 0000-0001-8696-9995 Teresa Espinosa-BuitragoDepartamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, Pza. Ramón y Cajal s/n, 28040 Madrid, Spain.ORCID 0000-0002-6435-4380 Yeny Morales-MorenoCentro de Bioactivos Químicos, Universidad Central "Marta Abreu" de Las Villas, Santa Clara 54800, Villa Clara, Cuba.
Vicente Arán-RedóInstituto de Química Médica del Consejo Superior de Investigaciones Científicas de España, Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0002-3390-7157 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
3-alkoxy-1-benzyl-5-nitroindazoleBALB/c micecutaneous leishmaniasisin vivo antileishmanial activityLeishmania amazonensisneglected tropical diseases
Identifiers
PMID40872500
PMCPMC12389175
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390